Literature DB >> 708997

Demonstration of 5-hydroxytryptamine receptors through inhibition by methergoline in cat pial arteries in vitro.

L Edvinsson, J E Hardebo.   

Abstract

1 In an attempt to characterize further the nature of the 5-hydroxytryptamine (5-HT)-induced contraction of intracranial vessels, cat's middle cerebral artery was exposed to this amine and the specific 5-HT receptor antagonist, methergoline, under standardized conditions in vitro. Methergoline, in increasing concentrations, produced a parallel shift of the log dose-response curve for 5-HT. 2 The Arunlakshana-Schild plot gave a straight line with a slope of -0.85. The figure corresponding to the pA2 value was 8.80. 3 The findings offer further support for the assumption that the 5-HT-induced intracranial vasoconstriction is mediated by specific 5-HT receptors.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 708997      PMCID: PMC1668316          DOI: 10.1111/j.1476-5381.1978.tb17301.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  7 in total

1.  Influence of initial tension and changes in sensitivity during amine-induced contractions of pial arteries in vitro.

Authors:  L Edvinsson; K C Nielsen; C Owman
Journal:  Arch Int Pharmacodyn Ther       Date:  1974-04

2.  Antagonism of central effects of tryptamine and 5-hydroxytryptophan by 1,6-dimethyl-8beta-carbobenzyloxy-aminomethyl-10alpha-ergoline. Interference with amphetamine and DOPA.

Authors:  R Ferrini; A Glässer
Journal:  Psychopharmacologia       Date:  1965-11-16

3.  Pharmacological analysis of 5-hydroxytryptamine receptors in isolated intracranial and extracranial vessels of cat and man.

Authors:  L Edvinsson; J E Hardebo; C Owman
Journal:  Circ Res       Date:  1978-01       Impact factor: 17.367

4.  1-Methyl-8-beta-carbobenzyloxy-aminomethyl-10-alpha-ergoline, a potent and long-lasting 5-hydroxytryptamine antagonist.

Authors:  C Beretta; R Ferrini; A H Glässer
Journal:  Nature       Date:  1965-07-24       Impact factor: 49.962

5.  Serotonin antagonism in isolated canine cerebral arteries.

Authors:  N Toda; S Hayashi; W L Fu; Y Nagasaka
Journal:  Jpn J Pharmacol       Date:  1976-02

6.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03

7.  Indoleamine antagonists: relative potencies as inhibitors of tryptamine- and 5-hydroxytryptophan-evoked responses.

Authors:  B V Clineschmidt; V J Lotti
Journal:  Br J Pharmacol       Date:  1974-02       Impact factor: 8.739

  7 in total
  2 in total

1.  Analysis of the 5-hydroxytryptamine induced contraction of the human basilar arterial strip compared with the rat aortic strip in vitro.

Authors:  C Forster; E T Whalley
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-04       Impact factor: 3.000

2.  Vascular smooth muscle response to fibrinogen degradation products and 5-hydroxytryptamine: possible role in cerebral vasospasm in man.

Authors:  C Forster; E T Whalley; J Mohan; J Dutton
Journal:  Br J Clin Pharmacol       Date:  1980-09       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.